1. Home
  2. CCCC vs HPP Comparison

CCCC vs HPP Comparison

Compare CCCC & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • HPP
  • Stock Information
  • Founded
  • CCCC 2015
  • HPP 2009
  • Country
  • CCCC United States
  • HPP United States
  • Employees
  • CCCC N/A
  • HPP N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • HPP Real Estate
  • Sector
  • CCCC Health Care
  • HPP Finance
  • Exchange
  • CCCC Nasdaq
  • HPP Nasdaq
  • Market Cap
  • CCCC 244.9M
  • HPP 420.6M
  • IPO Year
  • CCCC 2020
  • HPP 2010
  • Fundamental
  • Price
  • CCCC $3.64
  • HPP $3.16
  • Analyst Decision
  • CCCC Buy
  • HPP Hold
  • Analyst Count
  • CCCC 6
  • HPP 11
  • Target Price
  • CCCC $10.67
  • HPP $4.75
  • AVG Volume (30 Days)
  • CCCC 1.9M
  • HPP 3.0M
  • Earning Date
  • CCCC 02-20-2025
  • HPP 02-20-2025
  • Dividend Yield
  • CCCC N/A
  • HPP 3.16%
  • EPS Growth
  • CCCC N/A
  • HPP N/A
  • EPS
  • CCCC N/A
  • HPP N/A
  • Revenue
  • CCCC $33,668,000.00
  • HPP $847,713,000.00
  • Revenue This Year
  • CCCC $75.79
  • HPP N/A
  • Revenue Next Year
  • CCCC N/A
  • HPP $0.04
  • P/E Ratio
  • CCCC N/A
  • HPP N/A
  • Revenue Growth
  • CCCC 65.45
  • HPP N/A
  • 52 Week Low
  • CCCC $3.25
  • HPP $2.39
  • 52 Week High
  • CCCC $11.88
  • HPP $8.17
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 41.72
  • HPP 49.19
  • Support Level
  • CCCC $3.25
  • HPP $2.94
  • Resistance Level
  • CCCC $3.84
  • HPP $3.23
  • Average True Range (ATR)
  • CCCC 0.20
  • HPP 0.21
  • MACD
  • CCCC -0.01
  • HPP 0.02
  • Stochastic Oscillator
  • CCCC 29.49
  • HPP 34.75

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

About HPP Hudson Pacific Properties Inc.

Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.

Share on Social Networks: